Symbotic

Symbiotic opened in pre-market trading at $40.33, falling to a low of $40.035 before rallying sharply after earnings were released. In regular trading, it rose steadily from $41.045 to $41.605, closing up 5.1% at $41.62. While Q3 revenue of $721 million and net income of $11.7 million both showed strong year-over-year growth, the stock had previously fallen 10.3% on an earnings miss. Today's rebound was driven by a post-earnings sentiment recovery and an investor presentation outlining its AI-powered warehouse automation platform. However, the stock remains 52.64% below its 52-week high of $87.88 and 35.84% YTD, and is trading below its 20-day moving average of $42.50, indicating continued technical weakness.

Symbotic opened sharply lower in regular trading on Nasdaq, with the first trade at $43.717, down approximately 6.0% from the prior close of $46.520, driven by pre-market weakness (low of $43.800) and persistent insider selling following earnings—the CTO and CSO had recently disposed of over $766K and $376K in shares, respectively. Despite Q3 FY2026 revenue of $720.8M (+21.7% YoY, slightly above estimates) and net income surging 297% YoY to $11.7M, the stock remains 50.1% below its 52-week high of $87.88 and trades below the 60-day MA of $44.397, though above the 20-day MA of $42.816; year-to-date it is down 32.4%. However, operating income more than doubled YoY to $32.9M and net margin improved to 1.62%, while ROE jumped from 1.17% in Q2 to 6.69%.

Symbotic staged a strong intraday rally, surging 5.0% to $45.21 as of ET 10:37, fully reversing pre-market weakness around $43.05, driven by improving earnings. Q2 2026 net profit jumped 209.15% YoY to $1.97M, operating income rose 149.07% YoY, revenue grew 23.07% to $676.48M, with EPS of $0.01, marking a second consecutive quarter of profitability. The stock remains 48.55% below its 52-week high of $87.88 but has reclaimed the 20-day MA ($42.20) and is approaching the 60-day MA ($44.76), trimming its YTD loss to 30.31%. However, post-market quotes slipped to $42.50, suggesting cautious follow-through.

SYM.US surged 6.5% to close at $42.965, driven by strong pre-market buying, hitting an intraday high of $43.03 before consolidating. Recent insider selling (CTO disposed over $766K, CSO $376K) raised concerns, but Q2 revenue grew 23.07% YoY to $676.48M, net profit turned positive to $1.969M, and EPS improved to $0.01. The stock remains 51.11% below its 52-week high of $87.88 and below the 60-day MA ($45.28), though it has reclaimed the 20-day MA ($42.15), suggesting near-term momentum is building.

Symbotic fell sharply during regular trading, closing down 4.4% at $40.61, as market caution ahead of the upcoming earnings report weighed on sentiment. The stock briefly rose in pre-market but reversed lower, with the intraday range spanning from $42.765 to $40.230, touching a new low since June 23, 2026. Despite Q2 operating revenue of $676.48 million (+23% YoY) and net profit surging 209% to $1.97 million, the stock remains 53.8% below its 52-week high of $87.88 and trades below both the 20-day (42.49) and 60-day (46.65) moving averages, indicating persistent valuation pressure. However, an analyst price target increase to $67.14 suggests potential upside, while the recent acquisition of UK software firm ARMS Innovations adds a strategic growth angle.